Nursing home giant Kindred Healthcare Inc. is reporting net quarterly profit sharply lower from a year ago.
Diabetes growth to drive wound market
By
Elizabeth Newman
Nov 01, 2014
A rise in diabetes and obesity will drive the increase in the wound care market over the next four years, a research group asserts.
Psychologists plead guilty in $25 million SNF fraud scheme
By
Sep 09, 2016
Two psychologists pleaded guilty on Wednesday to charges that they billed Medicare millions of dollars for psychological tests unnecessarily administered to nursing home residents.
Ventas signs deal to acquire Atria Senior Living for $3.1 billion
Oct 25, 2010
Ventas Inc. announced its agreement to purchase Atria Senior Living Group—the fourth-largest assisted living property operator in the United States—for $3.1 billion.
Federal government sues provider after workers are fired for seeking religious exemption to flu shot
By
Apr 29, 2016
A North Carolina-based healthcare provider has been hit with a lawsuit from the federal government for allegedly firing three employees who asked for a religious exemption from the company’s mandatory...
Also in the news for Oct. 24, 2014 . . .
Oct 24, 2014
CMS launches $840 million initiative to encourage clinician collaboration … Americans distrust medical professionals, Harvard researchers find … Future uncertain for NYC nursing home dedicated...
NHI makes $26M in acquisitions
Apr 24, 2013
National Health Investors, Inc. announced last week that it had acquired skilled nursing facilities with a total of 254 beds for $26.3 million.
DM Systems introduces product that protects heels
May 31, 2011
DM Systems Inc. recently unveiled HeelSafe DVT Hose. The product includes a unique patented window design that relieves pressure on the heel and Achilles tendon while also allowing for easy visualization...
Smith & Nephew acquires Kalypto Medical
May 09, 2012
Smith & Nephew announced the closing of the acquisition of privately-held Kalypto Medical Inc. The acquisition helps bolster Smith & Nephew’s Negative Pressure Wound Therapy portfolio. Kalypto Medical...
FDA approves medicine for treatment of deep vein thrombosis
Jul 06, 2011
The Food and Drug Administration has approved Janssen Pharmaceuticals, Inc.’s Xarelto (rivaroxaban ). Xarelto is intended for the treatment of deep vein thrombosis (DVT). If all or part of a DVT...